Bionovate Technologies Corp (BIIO)
0.00
USD |
OTCM |
Apr 22, 16:00
Price Chart
Key Stats
Dividend | |
---|---|
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | -- |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 100.0% |
Profile
Bionovate Technologies Corp is a medical device company. It is engaged in developing automated treatment systems for age spots (solar lentigines). The technology uses a scan and treat protocol that removes age spots accurately and completely without disturbing the surrounding skin area. |
URL | N/A |
Investor Relations URL | N/A |
HQ State/Province | N/A |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Equity Style | Small Cap/Blend |
Next Earnings Release | May. 13, 2024 (est.) |
Last Earnings Release | N/A |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |
Ratings
Profile
Bionovate Technologies Corp is a medical device company. It is engaged in developing automated treatment systems for age spots (solar lentigines). The technology uses a scan and treat protocol that removes age spots accurately and completely without disturbing the surrounding skin area. |
URL | N/A |
Investor Relations URL | N/A |
HQ State/Province | N/A |
Sector | Health Care |
Industry | Health Care Equipment & Supplies |
Equity Style | Small Cap/Blend |
Next Earnings Release | May. 13, 2024 (est.) |
Last Earnings Release | N/A |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | N/A |